Papillary Balloon Dilation Versus Intraductal Lithotripsy

Sponsor
University of Southern California (Other)
Overall Status
Recruiting
CT.gov ID
NCT03536247
Collaborator
(none)
90
2
2
74.8
45
0.6

Study Details

Study Description

Brief Summary

Our aim is to compare the efficacy, safety, procedural time required, and costs of a strategy initially employing cholangioscopy guided intraductal lithotripsy (laser/electrohydraulic lithtripsy (EHL)) versus a strategy initially using papillary dilation for removal of large bile duct stones.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Initial therapy with papillary balloon dilation
  • Procedure: Initial therapy with intraductal lithotripsy
N/A

Detailed Description

The study will be a prospective single blind randomized comparative trial. All patients presenting with choledocholithiasis will be considered for the study. If their ultrasound, computed tomography, or magnetic resonance imaging demonstrates a large stone (>1cm) and they do not fulfill the exclusion criterion they will be eligible for the study. If a prior Endoscopic retrograde cholangiopancreatography (ERCP) demonstrates a stone >1cm, which could not be removed with standard methods, they will also be eligible. Randomization will be stratified based on whether or not the procedure is a first or repeat ERCP

Patients will be randomized using a computer generated randomization schedule with concealed allocation in a 1:1 assignment (allocation ratio) to initial cholangioscopy guided lithoripsy versus initial papillary dilation. Randomization will be blocked in groups of 12.

In those randomized to cholangioscopy-guided lithotripsy, the procedure will be performed in the standard manner using a single operator cholangioscopy system and a holmium laser or EHL (dependent on availability). Those in the papillary dilation arm will undergo the standard approach using the combined papillary dilation balloon sphincterotomy system. The patients will be blinded as to treatment arm.

"Conventional" methods including mechanical lithotripsy or stent placement may be used to remove stones/debris in combination with the specified intervention, as is done for standard clinical care. Use of these strategies will be recorded

If stone removal fails with the assigned strategy, this will be considered failure of the assigned intervention. This decision will be made by the attending endoscopist and recorded. The patient will then crossover into the other treatment arm.

The primary outcome will be complete stone clearance in the first study procedure by the assigned method. Additional outcomes will be total procedure time, cost of equipment, and number and type of complications. Additional ERCP may be needed for complete removal in some cases (i.e. complete removal in first attempt is not possible), thus we will also compare the number of ERCP needed for final stone clearance and whether stone removal is eventually achieved by endoscopic methods (comparison will be on an intention to treat basis). Additionally, if patients require surgical stone removal for the standard clinical indication in the case that endoscopic strategies are not successful, this will be recorded.

The patients will be followed clinically by the principal investigator assisted by a research coordinator on days 1,7 and 30 post procedures. This will be done as a brief follow up visit if the patient is still hospitalized or by telephone call thereafter.

Thus, all procedures performed in this study represent standard clinical care, which would be used even if the patients did not take part in the study, except that the initial choice to use cholangioscopy guided lithotripsy versus papillary dilation will be randomized.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients will be randomized using a pre-generated randomization schedule with concealed allocation in a 1:1 assignment to initial cholangioscopy guided lithotrispy or papillary dilation. Randomization will be blocked in groups of 12.Patients will be randomized using a pre-generated randomization schedule with concealed allocation in a 1:1 assignment to initial cholangioscopy guided lithotrispy or papillary dilation. Randomization will be blocked in groups of 12.
Masking:
Single (Participant)
Masking Description:
Participants in the study will be blinded to treatment arm. Care providers and Investigators will be unblinded to treated arm.
Primary Purpose:
Treatment
Official Title:
Prospective Randomized Trial of Cholangioscopy Guided Intraductal Lithotripsy Versus Papillary Balloon Dilation for the Endoscopic Treatment of Large Bile Duct Stones
Actual Study Start Date :
Sep 7, 2018
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intraductal lithotripsy

Cholangioscopy enables therapeutic intervention including intracorporeal electro-hydraulic and laser lithotripsy for biliary stone disease with favorable efficacy and safety.

Procedure: Initial therapy with intraductal lithotripsy
patients will first undergo intraductal laser or electrohydraulic lithrotripsy

Active Comparator: Papillary Balloon dilation

Balloon dilation of the Ampulla of Vater after a small sphincterotomy is an alternative technique that allows for removal of large bile duct stones in a safe and effective manner.

Procedure: Initial therapy with papillary balloon dilation
patients will first undergo papillary dilation
Other Names:
  • papillary dilation
  • Outcome Measures

    Primary Outcome Measures

    1. First procedure stone clearance [2 hours]

      Entire stone[s] removed in first procedure

    Secondary Outcome Measures

    1. Adverse Events [1 week]

      Pancreatitis, bleeding, perforation, infection

    2. Procedure Time [2 hours]

      Length of procedure

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 115 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients 18 years and older

    • Undergoing ERCP at LAC+Medical Center or Keck Hospital of USC for the standard indication of bile duct stones with evidence of a large stone (>1cm) demonstrated either on Ultrasound, computed tomography, prior ERCP, or magnetic resonance imaging.

    Exclusion Criteria:
    • Patients Under the age of 18

    • Patients with biliary malignancy

    • Prior biliary diversion surgery

    • Prior gastric bypass surgery

    • Patients who are incarcerated

    • Patients who are unable to give consent

    • Patients who pregnant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Keck Hospital of USC Los Angeles California United States 90033
    2 Los Angeles County + USC Medical Center Los Angeles California United States 90033

    Sponsors and Collaborators

    • University of Southern California

    Investigators

    • Principal Investigator: Ara Sahakian, MD, University of Southern California
    • Principal Investigator: James Buxbaum, MD, University of Southern California

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Ara Sahakian, Assistant Professor of Medicine, University of Southern California
    ClinicalTrials.gov Identifier:
    NCT03536247
    Other Study ID Numbers:
    • HS-17-00448
    First Posted:
    May 24, 2018
    Last Update Posted:
    Jun 15, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Ara Sahakian, Assistant Professor of Medicine, University of Southern California
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 15, 2022